Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Ling Chen

Ling Chen

Shanghai East Hospital, China

Title: What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension?

Biography

Biography: Ling Chen

Abstract

Our clinical study show that low current and low frequency electroacupuncture at P5-6 (overlying median nerve) and S36-37 (overlying deep peroneal nerve) reduces high blood pressure in a subset of patients (~70%) with mild to moderate hypertension.  The effect is slow in onset (4-8 weeks) but is long-lasting (1-2 months).  Experimental studies have shown that EA inhibits cardiovascular sympathoexcitatory neurons through activation of neurons in the arcuate nucleus of the hypothalamus, ventrolateral periaqueductal gray (vlPAG) in the midbrain and nucleus raphe pallidus (NRP) in the medulla, which in turn, inhibits the activity of premotor sympathetic neurons in the rostral ventrolateral medulla (rVLM) to ultimately reduce blood pressure.  Several neurotransmitters such as glutamate, acetylcholine, opioids, GABA, nociceptin, serotonin and endocannabinoids participate in the EA hypotensive response although their importance varies between nuclei.  The long-lasting inhibition of EA is related to opioids and GABA in the rVLM, neural circuitry between the arcuate and vlPAG, and prolongation of the increase in preproenkephalin mRNA and enkephalin expression in the rVLM and arcuate.  The inhibition of sympathetic activity, renin, angiotensin and aldosterone may be quite important.  Thus, a number of mechanisms underlying the actions and long-lasting effect of EA on cardiovascular function have been identified, but clearly further investigation is warranted.